Nyloxin

Manufacturer
Nutra Pharma Corporation
Effective date
2025-10-14
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 02:37:07

Label at a glance#

ProductNyloxin
Active ingredientNAJA NAJA VENOM
Label structure8 sections

Indications and uses

Temporarily relieves joint pain associated with overuse and pain associated with arthritis.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Analgesic Topical Gel

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Asian Cobra Venom 4x

Purpose

OTC - PURPOSE SECTION

Analgesic*

*According to the Homeopathic Pharmacopeia of the United States

Uses:

INDICATIONS & USAGE SECTION

Temporarily relieves joint pain associated with overuse and pain associated with arthritis.

Warnings:

WARNINGS SECTION

  • For external use only
  • If symptoms persist or worsen, discontinue use and seek medical attention.
  • Avoid contact with eyes. If product gets into eyes, flush with water. Seek medical attention.
  • Not for use on open wounds.

Directions For Use:

DOSAGE & ADMINISTRATION SECTION

  • Remove protective wrapping.
  • Liberally apply gel to the affected area and rub into joints.
  • Use 3-4 times per day for the first week. Use as needed thereafter to relieve discomfort.
  • Allow several days for drug to take maximum effect.

Other Information:

OTHER SAFETY INFORMATION

OTC - DO NOT USE SECTION

  • Do not use if container seal is broken prior to opening.
  • This product is intended for use in cases of recurring joint pain.
  • This product is NOT intended to treat disease, it provides a temporary level of comfort, relief and a feeling of wellness.
  • This product has been determined to be safe and effective for moderate to severe (Stage 2) chronic pain, as indicated by the Homeopathic Pharmacopeia of the United States.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • Pregnant or nursing women and children should consult a physician before use.

Inactive Ingredients:

INACTIVE INGREDIENT SECTION

Benzalkonium chloride, Ethanol, Methocel, Propylene glycol, Saline

Principal Display Panel - 8 oz Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Chronic Pain Relief

Nyloxin™

TOPICAL GEL
PROFESSIONAL SIZE

• Safe and Effective
• Long Lasting
• Easy to Use
• Scent Free
• Non-Narcotic
• Non-Addictive
• Analgesic and Anti-inflammatory
• Works on Multiple Types of Chronic Pain

• Joint Pain
• Neck Pain
• Arthritis Pain
• Pain from Repetitive Stress

BREAKTHROUGH
Stage 2
Pain Relief

8 oz. net wt.

Made in the U.S.A.

Principal Display Panel - 8 oz Carton Label
Principal Display Panel - 8 oz Carton Label

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130347219300089GTIN-13: 0347219300089
EAN-13: 0347219300089
GTIN-12: 347219300089
UPC-A: 347219300089
GTIN storage (14 digits): 00347219300089
nyl02-0000-01.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7792dadb-52b6-46b6-8fdf-80b1171065b5Product name120180810
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
47219-300-08Nyloxin1 in 1 BOXGEL15
47219-300-08Nyloxin235 mL in 1 BOTTLE, DISPENSINGGEL2355

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
NAJA NAJA VENOMACTIVE INGREDIENTZZ4AG7L7VM1
NAJA NAJA VENOMACTIVE MOIETYZZ4AG7L7VM1
AlcoholINACTIVE INGREDIENT3K9958V90M1
Benzalkonium ChlorideINACTIVE INGREDIENTF5UM2KM3W71
Hydroxypropyl CelluloseINACTIVE INGREDIENTRFW2ET671P1
Propylene GlycolINACTIVE INGREDIENT6DC9Q167V31
Sodium ChlorideINACTIVE INGREDIENT451W47IQ8X1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
47219-30047219-300-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
42021-07-14full-release2026-06-01 02:14:40

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 24 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7OINTMENT / TOPICAL0.03 %w/wExact identifier — unii+route
16 equally ranked IID candidates
AlcoholALCOHOL3K9958V90MGEL / TOPICAL9971 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION / TOPICAL0.02 %w/vExact identifier — unii+route
16 equally ranked IID candidates
Hydroxypropyl CelluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PGEL / TOPICAL222 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XGEL / TOPICAL0.18 %w/wExact identifier — unii+route+dosage form
2 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7OINTMENT / TOPICAL0.03 %w/wExact identifier — unii+route
16 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7LOTION / TOPICAL0.1 %w/wExact identifier — unii+route
16 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3GEL / TOPICAL4522 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7CLOTH / TOPICALNAExact identifier — unii+route
16 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7CLOTH / TOPICALNAExact identifier — unii+route
16 equally ranked IID candidates
AlcoholALCOHOL3K9958V90MGEL / TOPICAL9971 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7GEL / OPHTHALMIC0.01 %w/wExact identifier — unii+dosage form
16 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3GEL / TOPICAL4522 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / TOPICAL0.01 %w/vExact identifier — unii+route
16 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / TOPICAL0.01 %w/vExact identifier — unii+route
16 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SUSPENSION/ DROPS / TOPICALNAExact identifier — unii+route
16 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7LOTION / TOPICAL0.1 %w/wExact identifier — unii+route
16 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SHAMPOO / TOPICAL0.2 %w/wExact identifier — unii+route
16 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7GEL / OPHTHALMIC0.01 %w/wExact identifier — unii+dosage form
16 equally ranked IID candidates
Hydroxypropyl CelluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PGEL / TOPICAL222 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SHAMPOO / TOPICAL0.2 %w/wExact identifier — unii+route
16 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SUSPENSION/ DROPS / TOPICALNAExact identifier — unii+route
16 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION / TOPICAL0.02 %w/vExact identifier — unii+route
16 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XGEL / TOPICAL0.18 %w/wExact identifier — unii+route+dosage form
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NyloxinNAJA NAJA VENOMNutra Pharma Corporation0ea98615-f6d3-4f74-8faf-c828b7cfc7d32025-10-14WarningsExact identifier
ndc (package): 47219-300-08
ndc (product): 47219-300
ndc11 (package): 47219030008
spl id: bbccd2a6-c675-4b2a-a7cf-36fc46580f56
spl set id: 0ea98615-f6d3-4f74-8faf-c828b7cfc7d3
NyloxinNAJA NAJA VENOMNutra Pharma Corporation289ce7d2-9e9e-4792-92b5-de326007da332025-10-14WarningsExact identifier
ndc (product): 47219-300

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.